Weighing Obesity Risk: FDA, EMEA Use Different Scales For Abbott's Meridia
Abbott is withdrawing its anti-obesity drug sibutramine from the European Union markets at the urging of the European Medicines Agency
Abbott is withdrawing its anti-obesity drug sibutramine from the European Union markets at the urging of the European Medicines Agency